UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle

Biochemical journal, 2013-11, Vol.456 (1), p.119-128

2013

Volltextzugriff (PDF)

Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease

Proceedings of the National Academy of Sciences - PNAS, 2014-02, Vol.111 (7), p.2626-2631

2014

Volltextzugriff (PDF)

The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation

Biochemical journal, 2012-08, Vol.446 (1), p.99-111

2012

Volltextzugriff (PDF)

Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?

BMC medicine, 2012-02, Vol.10 (1), p.20-20, Article 20

2012

Volltextzugriff (PDF)

Heterogeneity of Leucine-Rich Repeat Kinase 2 Mutations: Genetics, Mechanisms and Therapeutic Implications

Neurotherapeutics, 2014-10, Vol.11 (4), p.738-750

2014

Volltextzugriff (PDF)

Hexokinase activity is required for recruitment of parkin to depolarized mitochondria

Human molecular genetics, 2014-01, Vol.23 (1), p.145-156

2014

Volltextzugriff (PDF)

The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research

Biochemical journal, 2016-02, Vol.473 (3), p.221-232

2016

Volltextzugriff (PDF)

Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7

Nature communications, 2014-12, Vol.5 (1), p.5827-5827, Article 5827

2014

Volltextzugriff (PDF)

The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2

Biochemical journal, 2017-04, Vol.474 (9), p.1547-1558

2017

Volltextzugriff (PDF)

mRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex

Nature neuroscience, 2013-04, Vol.16 (4), p.499-506

2013

Volltextzugriff (PDF)

Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice

Human molecular genetics, 2018-09, Vol.27 (18), p.3257-3271

2018

Volltextzugriff (PDF)

14-3-3 proteins are promising LRRK2 interactors

Biochemical journal, 2010-09, Vol.430 (3), p.e5-e6

2010

Volltextzugriff (PDF)

Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2

Neurochemical research, 2019-06, Vol.44 (6), p.1446-1459

2019

Volltextzugriff (PDF)

Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation

The Journal of clinical investigation, 2014-07, Vol.124 (7), p.3032-3046

2014

Volltextzugriff (PDF)

Refractory Contactin-1-seropositive chronic inflammatory demyelinating polyneuropathy with involvement of cranial nerves: A case report. (P2.2-107)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

Messenger RNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex

Nature neuroscience, 2013-02, Vol.16 (4), p.499-506

2013

Volltextzugriff (PDF)

Phosphorylation of LRRK2 by casein kinase 1[alpha] regulates trans-Golgi clustering via differential interaction with ARHGEF7

Nature communications, 2014-12, Vol.5, p.5827

2014

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle

Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease

The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation

Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?

Heterogeneity of Leucine-Rich Repeat Kinase 2 Mutations: Genetics, Mechanisms and Therapeutic Implications

Hexokinase activity is required for recruitment of parkin to depolarized mitochondria

The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research

Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7

The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2

mRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex

Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice

14-3-3 proteins are promising LRRK2 interactors

Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2

Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation

Refractory Contactin-1-seropositive chronic inflammatory demyelinating polyneuropathy with involvement of cranial nerves: A case report. (P2.2-107)

Messenger RNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex

Phosphorylation of LRRK2 by casein kinase 1[alpha] regulates trans-Golgi clustering via differential interaction with ARHGEF7

Suchergebnisse filtern